SCIRENT was founded as a cardiovascular CRO in 2012 with the vision to help clients develop innovative medical drugs and devices for patients with cardiovascular diseases. Our dedicated team of experienced clinical and regulatory professionals shares your enthusiasm for developing effective therapies for heart patients.
What makes us different from our competitors is our profound expertise in cardiovascular therapeutics and diagnostics. Our CRO offers access to an excellent network of dedicated trial sites in Europe and North America with extensive experience in cardiovascular trials. Our clients value our lean and agile management, which makes our performance generally faster and more efficient.
specialized cardiovascular sites
of our staff have an
countries covered with a strong
Hans-Dirk Düngen is the founder and CEO of SCIRENT. He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.
Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at SCIRENT. Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.
Our site network covers 17 countries across the globe with a focus on Europe and North America.
* Partner Network
We will get back to you soon.